Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Schering-Plough’s Intron A gets EU label change
The large five-year study confirms that sustained loss of serum hepatitis C virus (HCV) RNA six months following the completion of treatment with nonpegylated interferon alfa-2b (with or
The large five-year study confirms that sustained loss of serum hepatitis C virus (HCV) RNA six months following the completion of treatment with nonpegylated interferon alfa-2b (with or
AZ-003 is the combination of Alexza’s proprietary Staccato system with fentanyl, a drug belonging to the class of compounds known as opioid analgesics. AZ-003 is a hand-held, electrically-heated,
UCB also reported that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a positive opinion, recommending the approval of
The data monitoring board (DMB) analyzed the efficacy data as assessed by the blinded independent progression review panel on the first 354 progression-free survival (PFS) events and also
In addition to improving insulin function and lowering blood sugar levels, recent research shows that these particular polyphenols also act as antioxidants, guarding the body from the damaging
Watson’s pravastatin sodium product is the authorized generic version of Bristol-Myers Squibb’s Pravachol and is indicated along with diet to reduce the risk of both first heart attack
In a multi-product deal potentially worth over $75 million, FivePrime will receive an upfront fee and research support, and Boehringer Ingelheim has exclusive worldwide rights to develop and
Under the terms of the agreement, Cellgate will perform studies to evaluate the feasibility of using its technology to topically deliver ISA247. These studies will commence over the
The study has been reviewed and approved by both the FDA and by the institutional review board (IRB) of the University of California, Irvine (UCI). Patient screening for
The company says this new technology may enable the creation of virtually any multifunctional protein for diverse applications. For example, one potential application is to connect multiple antibody